Libya vs Turks and Caicos Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Libya
0.2%
in 2024
Turks and Caicos Islands
0.2%
in 2024
Libya rank
98th
Turks and Caicos Islands rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Libya
- Turks and Caicos Islands
How they compare
Libya currently reports 0.2% against 0.2% in Turks and Caicos Islands, a difference of 0.0%.
Across all 10 years both countries report, Turks and Caicos Islands has been ahead every year.
Libya ranks 98th and Turks and Caicos Islands ranks 98th of 246 countries.
Turks and Caicos Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Libya | Turks and Caicos Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Turks and Caicos Islands |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Libya or Turks and Caicos Islands?
- Libya, at 0.2% against 0.2% in Turks and Caicos Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Libya and Turks and Caicos Islands?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Turks and Caicos Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Libya and Turks and Caicos Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Libya ranks 98th and Turks and Caicos Islands ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.